Hypertension and its effects on the economy of the health system for patients and society: Suggestions for developing countries

American Journal of Hypertension

Volumn 27, Issue 4, 2014, Pages 635-636

  Arredondo, Armando ^a   Avilés, Raúl ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

COST OF ILLNESS; DEVELOPING COUNTRY; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; HYPERTENSION; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; RISK FACTOR; SELF CARE; BLOOD; ECONOMICS; FEMALE; MALE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ANTIHYPERTENSIVE AGENT; RENIN;

ANTIHYPERTENSIVE AGENTS; FEMALE; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; MALE; MODELS, ECONOMIC; RENIN;

EID: 84897860772     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu010     Document Type: Letter

References (4)

1. Arno P, Viola D. Hypertension treatment at the crossroads: a role for economics? Am J Hypertension 2013; 26:1257-1259.
2. Campos I, Rojas R, Pedroza A, Medina C, Barquera S. Hipertensión arterial: prevalencia, diagnóstico oportuno, control y tendencias en adultos mexicanos. Sal Pub México 2013; 55:S144-S150.
3. Arredondo A, Zúñiga A. Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico. Cad Saúde Publica 2012; 28:497-502.
4. Arredondo A, Aviles R, De Icaza E, National Institute of Public Health. Costos de enfermedades crónicas en México. Informe Técnico de Memoria Metodológica. Technical Report. National Institute of Public Health: Cuernavaca, México, 2013, pp. 23-27.